What is the recommended dose of diazepam (Diazepam) for intubation?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 30, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Diazepam Dosing for Intubation

The recommended dose of diazepam for intubation is 0.2-0.4 mg/kg IV/IO as a bolus, with a maximum single dose of 20 mg regardless of patient weight. 1

Adult Dosing

  • Initial dose: 5-10 mg IV administered over 1 minute 2
  • Additional doses may be administered at 5-minute intervals if needed for adequate sedation 2
  • For most intubation procedures, 10 mg IV is typically sufficient, though up to 20 mg may be necessary if not co-administering an opioid 2
  • For rapid sequence intubation, diazepam can be given as a 5 mg IV bolus followed by additional 5 mg aliquots each minute until adequate sedation is achieved (Ramsay sedation scale 5-6) 3

Pediatric Dosing

  • 0.2-0.4 mg/kg IV/IO for rapid sequence intubation 1
  • Maximum single dose: 20 mg 1

Clinical Considerations

Advantages of Diazepam for Intubation

  • Rapid onset of action with duration of approximately 10-15 minutes 1
  • Lowers intracranial pressure without significant blood pressure reduction, making it suitable for patients with head injury, multisystem trauma, or hypotension 1
  • May be more cost-effective than midazolam while providing similar sedation quality 3
  • Faster time to adequate sedation compared to midazolam (132 ± 87 sec vs. 224 ± 117 sec) 3

Special Populations

  • Dose reduction (20% or more) is required in:
    • Elderly patients 2, 1
    • Debilitated patients 2
    • Patients with hepatic or renal impairment 1
    • Obese patients 1

Administration Technique

  • Administer IV diazepam over approximately 1-2 minutes to avoid pain at injection site 2
  • When used for awake intubation, a dose of 0.1 mg/kg may be appropriate when combined with other agents like alfentanil 4

Potential Adverse Effects

  • Respiratory depression, especially when combined with opioids 2, 1
  • Coughing, dyspnea 2
  • Brief myoclonic activity (hiccups, twitching) 1
  • May exacerbate focal seizure disorders 1
  • Transient adrenal suppression (not clinically significant) 1
  • Potential for paradoxical excitement or agitation 2

Monitoring and Safety

  • Monitor oxygen saturation and respiratory effort during administration 2, 1
  • Be prepared to provide respiratory support if needed 2, 1
  • Have flumazenil available for reversal of severe respiratory depression: 0.01-0.02 mg/kg IV (maximum: 0.2 mg), repeatable at 1-minute intervals to maximum cumulative dose of 0.05 mg/kg or 1 mg 1
  • Use caution with flumazenil in benzodiazepine-dependent patients as it may precipitate acute withdrawal 1

Combination Therapy

  • When diazepam is used with an opioid (e.g., fentanyl), a synergistic interaction occurs, requiring dose reduction 2
  • For awake fiberoptic intubation, combining diazepam with alfentanil can improve intubation conditions and attenuate pressor responses 4

Comparison with Midazolam

  • Midazolam has a more rapid onset and shorter duration of effect compared to diazepam 2
  • Midazolam is often preferred by endoscopists due to its favorable pharmacologic profile 2
  • However, diazepam provides faster time to adequate sedation for intubation with similar duration of effect 3
  • Diazepam is generally more cost-effective than midazolam for intubation purposes 3

References

Guideline

Sedation Prior to Intubation

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Diazepam or midazolam for orotracheal intubation in the ICU?

Revista da Associacao Medica Brasileira (1992), 2015

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.